Impact of Magnetic Stimulation on Pain in Endometriosis Patients
Pelvic Functional Magnetic Stimulation on Pain in Endometriosis Patients - a Prospective Non Randomised, Non-blinded Single Centre Observational Trial
2 other identifiers
interventional
30
0 countries
N/A
Brief Summary
Many women with endometriosis still experience pain despite surgical and medical treatment. Over-the-counter painkillers are usually helpful in alleviating this pain. But for some patients, these medications eventually stop working. Pain then dominates their daily life. In this study, we are investigating the effects of magnetic stimulation using the "Tesla chair" and whether it can alleviate their pain
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2026
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 17, 2025
CompletedFirst Posted
Study publicly available on registry
December 5, 2025
CompletedStudy Start
First participant enrolled
January 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 1, 2028
December 5, 2025
November 1, 2025
1.9 years
November 17, 2025
November 24, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Decrease of PPAF-Score before and after treatment.
Relief of pain measured by changes in PPAF (Pelvic pain assessment form) score before and after the treatment. 0= no pain, 10 = unbearable pain
From enrollment to the end of tratment at end of week 7
Secondary Outcomes (1)
Decrease of PPAF-Score before and after treatment.
From enrollment to 3 months after completion of treatment
Other Outcomes (1)
Subjective experience of patients, decrease in analgetic use
From enrollment to 3 months after completion of treatment
Study Arms (1)
Tesla-Chair
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Patient has been informed about study
- Age ≥ 18 years
- Premenopausal
- histologically or laparoscopically or MRI confirmed endometriosis
- CPP (cyclical pelvic pain VAS ≥ 5)
- Pelvic floor hypertonicity
- Written informed consent
- sufficient German speaking
- Current endocrine therapy for \>= 3 months
You may not qualify if:
- Contraindications according manufactureres manual Tesla Chair
- Pregnancy or desire to become pregnant within the next 8 weeks
- Pelvic organ prolapses
- Genital infections
- Menstruation
- active malignancy, Malignant tumors
- Severe neurological diseases
- Cardiac arrhythmia
- Active internal medical devices e.g. cardiac pacemakers, medication, pumps etc.
- Ferromagnetic implants at or near the site of stimulation
- Recent surgery at the site of stimulation
- Thrombosis or thrombophlebitis
- Epilepsy or suspected epilepsy
- Acute stages of kidney stones
- Gastrointestinal and internal disease at the site of stimulation
- +7 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 17, 2025
First Posted
December 5, 2025
Study Start
January 1, 2026
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
April 1, 2028
Last Updated
December 5, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share